BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25599481)

  • 1. Predicting mortality after elective open-heart surgery using midregional-proadrenomedullin: is it time to scalp Acute Physiology and Chronic Health Evaluation IV?
    Wu AH; Hale K
    Crit Care Med; 2015 Feb; 43(2):494-5. PubMed ID: 25599481
    [No Abstract]   [Full Text] [Related]  

  • 2. Postoperative pro-adrenomedullin levels predict mortality in thoracic surgery patients: comparison with Acute Physiology and Chronic Health Evaluation IV Score*.
    Schoe A; Schippers EF; Struck J; Ebmeyer S; Klautz RJ; de Jonge E; van Dissel JT
    Crit Care Med; 2015 Feb; 43(2):373-81. PubMed ID: 25599464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up.
    Buendgens L; Yagmur E; Ginsberg A; Weiskirchen R; Wirtz T; Jhaisha SA; Eisert A; Luedde T; Trautwein C; Tacke F; Koch A
    Mediators Inflamm; 2020; 2020():7184803. PubMed ID: 32831638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Intensive Care National Audit and Research Centre Scoring System in a UK Adult Cardiac Surgery Population.
    Ariyaratnam P; Loubani M; Biddulph J; Moore J; Richards N; Chaudhry M; Hong V; Haworth M; Ananthasayanam A
    J Cardiothorac Vasc Anesth; 2015; 29(3):565-9. PubMed ID: 25575409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midregional proadrenomedullin reflects cardiac dysfunction in haemodialysis patients with cardiovascular disease.
    Yoshihara F; Ernst A; Morgenthaler NG; Horio T; Nakamura S; Nakahama H; Nakata H; Bergmann A; Kangawa K; Kawano Y
    Nephrol Dial Transplant; 2007 Aug; 22(8):2263-8. PubMed ID: 17395664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of Acute Physiology and Chronic Health Evaluation IV in Dutch intensive care units and comparison with Acute Physiology and Chronic Health Evaluation II and Simplified Acute Physiology Score II.
    Brinkman S; Bakhshi-Raiez F; Abu-Hanna A; de Jonge E; Bosman RJ; Peelen L; de Keizer NF
    J Crit Care; 2011 Feb; 26(1):105.e11-8. PubMed ID: 20869840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and correlates of midregional proadrenomedullin in the general population.
    Smith JG; Newton-Cheh C; Hedblad B; Struck J; Morgenthaler NG; Bergmann A; Wang TJ; Melander O
    Clin Chem; 2009 Aug; 55(8):1593-5. PubMed ID: 19541860
    [No Abstract]   [Full Text] [Related]  

  • 8. The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock.
    Supeł K; Kacprzak M; Zielińska M
    Biomarkers; 2017; 22(3-4):296-303. PubMed ID: 27788594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
    Funke-Kaiser A; Mann K; Colquhoun D; Zeller T; Hunt D; Simes J; Sullivan D; Sydow K; West M; White H; Blankenberg S; Tonkin AM;
    Int J Cardiol; 2014 Mar; 172(2):411-8. PubMed ID: 24508492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Midregional Proadrenomedullin as a Hemodynamic Severity Marker in Asymptomatic Carotid Artery Stenosis/Occlusion.
    Hattori Y; Kakino Y; Kiyoshige E; Ogata S; Nishimura K; Iida H; Ihara M
    Stroke; 2024 Jul; 55(7):e182-e184. PubMed ID: 38860369
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment.
    Buerger K; Uspenskaya O; Hartmann O; Hansson O; Minthon L; Blennow K; Moeller HJ; Teipel SJ; Ernst A; Bergmann A; Hampel H
    J Clin Psychiatry; 2011 Apr; 72(4):556-63. PubMed ID: 21208578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.
    Shah KS; Marston NA; Mueller C; Neath SX; Christenson RH; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney J; Schreiber D; deFilippi C; Hogan CJ; Diercks DB; Limkakeng A; Anand IS; Wu AH; Clopton P; Jaffe AS; Peacock WF; Maisel AS
    Acad Emerg Med; 2015 May; 22(5):554-63. PubMed ID: 25908114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality prediction after cardiac surgery: blood lactate is indispensible.
    Badreldin AM; Doerr F; Elsobky S; Brehm BR; Abul-dahab M; Lehmann T; Bayer O; Wahlers T; Hekmat K
    Thorac Cardiovasc Surg; 2013 Dec; 61(8):708-17. PubMed ID: 24338631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting outcomes for cardiac surgery patients after intensive care unit admission.
    Kramer AA; Zimmerman JE
    Semin Cardiothorac Vasc Anesth; 2008 Sep; 12(3):175-83. PubMed ID: 18805852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained value of proadrenomedullin as mortality predictor in severe sepsis.
    Andaluz-Ojeda D; Cicuéndez R; Calvo D; Largo E; Nogales L; Muñoz MF; Bueno P; Eiros JM; Gandía F; Bermejo-Martín JF
    J Infect; 2015 Jul; 71(1):136-9. PubMed ID: 25704281
    [No Abstract]   [Full Text] [Related]  

  • 17. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients.
    Zimmerman JE; Kramer AA; McNair DS; Malila FM
    Crit Care Med; 2006 May; 34(5):1297-310. PubMed ID: 16540951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin.
    Wang RL; Kang FX
    Chin J Traumatol; 2010 Jun; 13(3):152-7. PubMed ID: 20515592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality Prediction in Patients Admitted in Surgical Intensive Care Unit by Using APACHE IV.
    Wetr WW; Shoukat H; Muhammad Y; Gondal KM; Aslam I
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):877-880. PubMed ID: 27981919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.